INE07RO01027
INE07RO01027
SUPRIYA LIFESCIENCE LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 68.22B EUR | 81.86B EUR | 45.22B EUR | 60.5B EUR |
Enterprise Value | 67.43B EUR | 81.86B EUR | 44.9B EUR | 60.5B EUR |
Valuation Multiples | ||||
Trailing P/E | 34.39x | 41.27x | 21.63x | 44.85x |
Forward P/E | 21.85x | -- | -- | -- |
Price to Sales | 7.82x | 9.38x | 5.46x | 10.97x |
Price to Book | 5.7x | -- | 3.78x | -- |
EV/Revenue | 7.73x | 9.38x | 5.42x | 10.97x |
EV/EBITDA | 23.29x | 27.17x | 14.7x | 29.59x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |